Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2025-12-25 @ 4:23 AM
NCT ID:
NCT00862420
Eligibility Criteria:
Inclusion Criteria:
Documented symptomatic peripheral arterial disease (one or both of the following two primary criteria must be satisfied):
* Current intermittent claudication with Ankle Brachial Index (ABI) \< 0.90
* A history of intermittent claudication together with previous related intervention in a leg
Exclusion Criteria:
* Patients who had acute atherothrombotic events or any invasive therapies within 30 days before the randomization, or patients who planned any invasive therapies within 12 weeks after the randomization
* Bleeding diathesis, coagulopathy and present bleeding disease
* Previous intracranial bleeding or hemorrhagic stroke
* Uncontrolled hypertension
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT00862420
Study Brief:
Protocol Section:
NCT00862420